Craft

Guanhao Biotech

Stock Price

¥13.2

2023-08-30

Market Capitalization

¥3.5 B

2023-08-30

Revenue

¥356.8 M

FY, 2022

Guanhao Biotech Summary

Company Summary

Overview
Guanhao Biotech (冠昊生物科技股份有限公司) is a company that researches, develops, produces, and sells regeneration medical materials and implanted devices. It provides biological dura mater patches, chest general surgery department patching membranes, intraocular lens, asepsis biological wound, etc.
Type
Public
Status
Active
HQ
Guangzhou, CN | view all locations
Website
http://www.grandhopebio.com
Sectors

LocationsView all

3 locations detected

  • Guangzhou, Guang Dong Sheng HQ

    China

    No. 12, Yuyan Road

  • Beijing, Bei Jing Shi

    China

    18th Floor, Guoxing Building, No. 22, Capital Gymnasium South Road

  • Guangzhou, Guang Dong Sheng

    China

    Room 3805A, 38th Floor, R&F Yingkai Plaza, No. 16, Huaxia Road

Guanhao Biotech Financials

Summary Financials

Revenue (Q1, 2023)
¥111.7M
Gross profit (Q1, 2023)
¥86.1M
Net income (Q1, 2023)
¥24.1M
Cash (Q1, 2023)
¥127.3M
EBIT (Q1, 2023)
¥28.4M
Enterprise value
$3.5B

Footer menu